Gene therapy for lung cancer and mesothelioma

[11] INVIVO GENE-TRANSFER WITH RETROVIRAL VECTOR PRODUCER CELLS FOR TREATMENT OF EXPERIMENTAL BRAIN-TUMORS [J]. SCIENCE, 1992, 256 (5063) : 1550 - 1552

[12] Targeted tumor killing via an intracellular antibody against erbB-2 [J]. JOURNAL OF CLINICAL INVESTIGATION, 1995, 96 (06) : 2980 - 2989

[13] INTRATUMORAL INTERLEUKIN-2 IMMUNOTHERAPY - ACTIVATION OF TUMOR-INFILTRATING AND SPLENIC LYMPHOCYTES INVIVO [J]. CANCER IMMUNOLOGY IMMUNOTHERAPY, 1993, 36 (03) : 156 - 162

[14] Elshami AA, 1996, GENE THER, V3, P85

[15] Treatment of pleural mesothelioma in an immunocompetent rat model utilizing adenoviral transfer of the herpes simplex virus thymidine kinase gene [J]. HUMAN GENE THERAPY, 1996, 7 (02) : 141 - 148

[16] FUJIWARA T, 1993, CANCER RES, V53, P4129

[17] FUJIWARA T, 1994, CANCER RES, V54, P2287

[18] GARVER RI, 1994, GENE THER, V1, P46

[19] GEORGES RN, 1993, CANCER RES, V53, P1743

[20] HARRIS JD, 1994, GENE THER, V1, P170

[11] INVIVO GENE-TRANSFER WITH RETROVIRAL VECTOR PRODUCER CELLS FOR TREATMENT OF EXPERIMENTAL BRAIN-TUMORS [J]. SCIENCE, 1992, 256 (5063) : 1550 - 1552

[12] Targeted tumor killing via an intracellular antibody against erbB-2 [J]. JOURNAL OF CLINICAL INVESTIGATION, 1995, 96 (06) : 2980 - 2989

[13] INTRATUMORAL INTERLEUKIN-2 IMMUNOTHERAPY - ACTIVATION OF TUMOR-INFILTRATING AND SPLENIC LYMPHOCYTES INVIVO [J]. CANCER IMMUNOLOGY IMMUNOTHERAPY, 1993, 36 (03) : 156 - 162

[14] Elshami AA, 1996, GENE THER, V3, P85

[15] Treatment of pleural mesothelioma in an immunocompetent rat model utilizing adenoviral transfer of the herpes simplex virus thymidine kinase gene [J]. HUMAN GENE THERAPY, 1996, 7 (02) : 141 - 148

[16] FUJIWARA T, 1993, CANCER RES, V53, P4129

[17] FUJIWARA T, 1994, CANCER RES, V54, P2287

[18] GARVER RI, 1994, GENE THER, V1, P46

[19] GEORGES RN, 1993, CANCER RES, V53, P1743

[20] HARRIS JD, 1994, GENE THER, V1, P170